Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-17

FDA Approved: ZALEPLON — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Zaleplon submitted by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zaleplon (Zaleplon)

Snippet

SUPPL AP for ZALEPLON (ZALEPLON)